Delivery Order SPE2DB20D3104-SPE2DB24FV8R6

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,616.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the purchase of 4,566,249,298 units of Sulfamethoxazole-TMP SS Tablets, which are used for various medical treatments. The contract has an ultimate completion date of October 29, 2024 and was awarded on October 28, 2024. It is a firm fixed-price contract and...
This federal contract award, valued at $1,046.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,568,077,726 units of Sulfamethoxazole-TMP DS Tablets, a type of antibiotic medication. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This federal contract award, with ID SPE2DX15D3112|SPE2DX25FDZJZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,138,138 units of Sulfamethoxazole-TMP DS Tablets in lots of 100. The $12,502.19 firm fixed-price delivery order contract has a performance period through May 6, 2025. This award is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award, with a ceiling value of $1,487.34, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,425,569 tablets of the drug Sulfamethoxazole-TMP DS. The contract, which is a Delivery Order, has a firm fixed price and an ultimate completion date of August 13, 2024. This contract is not associated with a set-aside program and is likely part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of sulfamethoxazole-tmp DS tablets. The firm-fixed-price delivery order, valued at $1,937.50, is a part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $1,657.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SULFAMETHOXAZOLE-TMP DS TABLET 100S, with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,478.75, is for the delivery of 4567756510 Sulfamethoxazole-TMP DS Tablets in 100-count packages. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside and is an open competition award....
This federal contract award, valued at $1,674.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4562800718 SULFAMETHOXAZOLE-TMP DS TABLET UD 100S, with a period of performance through November 14, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,432.78 Firm Fixed Price Delivery Order is for the supply of 4566640994 - Sulfamethoxazole-TMP DS Tablet 100s, with a period of performance through December 9, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,481.60, is for the delivery of 4,567,984,128 tablets of Sulfamethoxazole-TMP DS, a generic antibiotic medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV8R6
    Delivery Order

This federal contract award, valued at $1,517.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,367 units of sulfamethoxazole-TMP DS tablets, with a completion date of August 7, 2024. This is a firm fixed-price delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:31 AM